Replies to post #91349 on Amarantus Bioscience Holdings Inc (AMBS)

[zoomboom]

my belief is that the announcement of the AMBS PD-LID Drug Candidate will be in conjunction with a Nice Size Grant to fund the Phase IIb Trial. we shall see

[kenbkb]

This is the sentence and the words (at least) that struck me!

We are continuing to accumulate data in at least one additional undisclosed orphan indication for MANF....

[zoomboom]

this is the company i believe AMBS has the LOI signed with :

“Dyskinesia is a top priority for the Foundation because of its impact on the quality of life of people living with Parkinson’s disease,” said Todd Sherer, PhD, CEO of The Michael J. Fox Foundation. “The results presented by PsychoGenics and Dr. Bjorklund show early promise in finding a potential treatment for dyskinesia, and we look forward to working with this team to drive their program forward.”